基于淀粉水凝胶的口服疫苗利用甲醛灭活菌对日本鳗鲡爱德华氏菌病的免疫刺激作用
本研究开发了基于淀粉水凝胶的口服(SHO)疫苗,使用甲醛灭活菌预防日本鳗鲡爱德华氏菌病,并与传统甲醛灭活菌(FKC)疫苗比较。细菌凝集试验显示SHO接种组凝集效价高于FKC接种组;攻毒后SHO组存活率高于FKC组,且SHO疫苗加强接种可诱导相似或更高的保护。两种疫苗均上调了免疫相关细胞因子水平。
要点
- SHO疫苗接种组细菌凝集效价高于FKC疫苗接种组。
- 攻毒后FKC组存活率(60%和70%)低于SHO组(70%至90%)。
- SHO疫苗加强接种产生的保护力与初次接种相似或更高。
核心结论
- SHO疫苗在日本鳗鲡中显示出免疫刺激作用,突显其作为水产养殖口服疫苗的潜力。
研究设计与样本
- 研究使用甲醛灭活菌制备淀粉水凝胶口服(SHO)疫苗,并与传统甲醛灭活菌(FKC)疫苗进行比较,通过细菌凝集试验和攻毒试验评估保护效果。
- 日本鳗鲡接种后四周,用爱德华氏菌(Edwardsiella tarda)进行攻毒,监测存活率。
主要发现
- 细菌凝集试验显示,SHO疫苗接种组的凝集效价高于FKC疫苗接种组。
- 攻毒后存活率:FKC组为60%(第一次试验)和70%(第二次试验),低于SHO组。
- 三次SHO接种组的存活率(第一次和第二次试验分别为):每日接种一次、共接种一天的组为70%和80%;接种四天和八天的两组均为80%和90%。
- 在46天时进行SHO疫苗加强接种,引发的保护力与初次接种后相似或更高。
- 与对照组相比,FKC和SHO接种均上调了所有免疫组鱼体中促炎细胞因子(白细胞介素-6、肿瘤坏死因子-α)和宿主防御细胞因子(干扰素-α)的水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Edwardsiellosis outbreaks cause significant losses in Japanese eel aquaculture. The causative agent, Edwardsiella tarda, is an intracellular pathogen, and the use of antibiotics has a limited effectiveness. As Japanese eels are sensitive to stress, injection vaccines are not recommended for treatment; immersion methods are less stressful, but not cost-effective. Alternatively, oral vaccination methods are more promising. The aim of this study was to develop a starch hydrogel-based oral (SHO) vaccine against edwardsiellosis in Japanese eel, using formalin-killed cells. To assess the protective effect, we compared SHO vaccine with the conventional formalin-killed cell (FKC) vaccine. A bacterial agglutination test showed that agglutination titers in SHO-vaccinated group were higher than in the FKC-vaccinated group. Japanese eel survival rate (%) was monitored after challenge by E. tarda at four weeks post-vaccination. Survival rates in the FKC group (60%, first trial; 70%, second trial) were lower than in SHO groups. Percentage survival rates in three SHO groups (first and second trials, respectively) were as follows: 70% and 80% in the group vaccinated once per day for one day; and 80% and 90% in both groups vaccinated for four and eight days. Additionally, a boost SHO vaccination at 46 days prompted a similar or even higher protection against edwardsiellosis than after the initial vaccination. Both FKC and SHO vaccination upregulated levels of pro-inflammatory cytokines (interleukin (IL)-6, tumor necrosis factor (TNF)-α), and host defense cytokine (interferon (IFN)-α) in all immunized groups of fish when compared with the control. These results reveal the immunostimulation effect of SHO vaccine in Japanese eel, emphasizing its potential as an oral vaccine in aquaculture.
引用
- Jun JW, Kang JW, Giri SS, et al. Immunostimulation by starch hydrogel-based oral vaccine using formalin-killed cells against edwardsiellosis in Japanese eel, Anguilla japonica. Vaccine. 2020. PMID: 32307278. doi:10.1016/j.vaccine.2020.03.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。